As amazing as yesterday (May 18) was for Moderna (MRNA), it literally was only the third best performing vaccine stock.
Vir Biotechnology was up 27% and Novavax (NVAX) was up 37%.
Vir released a paper saying that the antibody from SARS in 2003 does stop COVID development. They have a relationship with Glaxo (GSK).
https://www.wsj.com/articles/PR-CO-20200518-902932.
NVAX has been #1 in the vaccine chase. Here is YTD:
No comments:
Post a Comment